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ABSTRACT: Ac-MB21-NH2 (Ac-FASLLGKALKALAKQ-NH2) and dermaseptin S3(1-16)-NH2 (AL-
WKNMLKGIGKLAGK-NH2) are cationic amphipathic peptides with antimicrobial activity against a broad
spectrum of microorganisms including various fungi. The interaction of the peptides with liposomes was
studied by exploiting the tryptophan fluorescence of F1W-Ac-MB21-NH2 and dermaseptin S3(1-16)-
NH2. Spectral analysis and the use of quenchers indicate that the tryptophans of both peptides insert more
deeply in anionic than in zwitterionic liposomes. Membrane insertion correlates with the formation of an
R-helical peptide structure. Both peptides permeabilize liposomes composed of anionic, cylindric
phospholipids more efficiently than liposomes formed of zwitterionic, conic (phospho)lipids.
Eukaryotic and prokaryotic organisms produce antimicro-
bial peptides to defend themselves against invading patho-
genic organisms or to eliminate organisms that compete for
the same niche. Many of these antimicrobial peptides are
composed of 10-46 amino acids and permeabilize the plas-
ma membrane of the target organism. Some of these peptides
have a very narrow spectrum of activity, while others exert
their activity on a broad range of organisms. Especially the
latter might be interesting as food additives or as new anti-
biotics. The basis of the specificity is not understood. Many
microbicidal peptides, among which dermaseptins (1, 2),
have been isolated from frog skin (3). Dermaseptins kill
various microorganisms including Gram-positive and -nega-
tive bacteria, protozoa among which Leishmania mexicana
and Plasmodium falciparum, and yeasts and filamentous
fungi, among which the pathogenic Aspergillus fumigatus
and Aspergillus niger (3, 4). Two subgroups of dermaseptins
can be identified: dermaseptins b (six members) and der-
maseptins S (five members) (5). A strong synergy of action
of the different dermaseptins S has been observed. Combina-
tion of the dermaseptins S causes a 100-fold increase in the
efficiency of antimicrobial action (2). Shortening of the 30
amino acid dermaseptin S3 to dermaseptin S3(1-16)-NH2,
does not cause a decrease in antimicrobial activity (6),
although the resulting peptide is too short to span the
membrane.
In the present study the mechanisms of membrane per-
meabilization were investigated of the designed, synthetic,
antifungal peptide Ac-MB21-NH2 (Ac-FASLLGKALKA-
LAKQ-NH2) and of dermaseptin S3(1-16)-NH2 (ALWKN-
MLKGIGKLAGK-NH2). To this end the interaction of the
peptides with liposomes of different (phospho)lipid composi-
tion was studied.
MATERIALS AND METHODS
Materials. Dioleoylphosphatidylglycerol (PG),1 dioleoyl-
phosphatidylcholine (PC), dioleoylphosphatidylethanolamine
(PE), dioleoylglycerol, 1-palmitoyl-2-stearoyl-(5-doxyl)-sn-
glycero-3-phosphocholine (abbreviated 5-doxyl-PC), and
1-palmitoyl-2-stearoyl-(16-doxyl)-sn-glycero-3-phosphocho-
line (abbreviated 16-doxyl-PC) were purchased from Avanti
Polar Lipids Inc. (Birmingham, AL). L-R-Phosphatidylserine
(PS) from bovine brain and ergosterol were obtained from
Sigma. F1W-Ac-MB21-NH2, Ac-MB21-NH2, and dermasep-
tin S3(1-16)-NH2 were obtained from Affinity Research
Products Ltd., Exeter, EX6 8HD U.K.
Liposome Preparation. Phospholipids with or without
ergosterol (molar ratio ergosterol/phospholipid 0.8) dissolved
in organic solvent were dried under nitrogen; subsequently,
a small volume of ethanol was added, and the drying step
was continued. Multilamellar vesicles were formed by
vortexing in the presence of buffer and glass beads. Small
unilamellar vesicles were obtained by sonication (tip diameter
3 mm; Soniprep 150, MSE Ltd., Crawley, Sussex) of 500
íL of the multilamellar vesicles (3-6 mM phospholipid),
† These investigations were supported by The Netherlands Foundation
for Chemical Research (CW) with financial aid from The Netherlands
Organization for Scientific Research (NWO) and Unilever Research
Vlaardingen.
* Address correspondence to this author. Phone: (31) (50) 3632164.
Fax: (31) (50) 3632154. E-mail: A.J.M.Driessen@BIOL.RUG.NL.
‡ University of Groningen.
⊥ Present address: Biomade Foundation, Nijenborgh 4, 9747 AG
Groningen, The Netherlands.
§ Unilever Research.
| University of Amsterdam.
1 Abbreviations: PG, dioleoylphosphatidylglycerol; PC, dioleoylphos-
phatidylcholine; PE, dioleoylphosphatidylethanolamine; PS, L-R-phos-




11907Biochemistry 2000, 39, 11907-11912
10.1021/bi000917a CCC: $19.00 © 2000 American Chemical Society
Published on Web 09/07/2000
10 ím amplitude, pulses of 45 s on/15 s off, incubation on
ice under a stream of nitrogen, during 15-30 min until the
suspension was transparent. Metal particles and large vesi-
cles were removed by 10 min centrifugation at 5400g and
4 °C.
Membrane Potential Measurement. Liposomes (74 íM
final phospholipid concentration) containing 50 mM potas-
sium phosphate, pH 7.0, were suspended in 50 mM sodium
phosphate, pH 7.0, and valinomycin (250 nM) was added to
induce a transmembrane potential (¢ª). The ¢ª was
monitored by means of DiSC(3)5 fluorescence (7) using
excitation and emission wavelengths of 643 and 666 nm,
respectively. The slit widths were set at 10 nm. Corrections
were made for the peptide-induced decrease in DiSC(3)5
fluorescence in the absence of a ¢ª.
Measurement of Peptide Concentration. Peptide concen-
trations were determined by measuring the optical density
at 214 nm for MB21 ( ) 12 790.8 cm-1 M-1) and at 280
nm for the tryptophan-containing peptides ( ) 5600 cm-1
M-1).
Circular Dichroism. CD spectra were recorded on an Aviv
62A DS CD spectrometer. The temperature was kept constant
at 25 °C, and the sample compartment was flushed with N2.
Spectra are the averages of 5-10 scans, using a band- and
stepwidth of 1 nm. Experiments were performed in 50 mM
potassium phosphate, pH 7.0.
Fluorescence Measurements. Fluorescence was measured
with a Perkin-Elmer LS-50 spectrofluorometer. Tryptophan
fluorescence was measured using an excitation wavelength
of 280 nm with the excitation and emission slit widths set
at 2.5 and 5 nm, respectively. Experiments were performed
at 30 °C in 50 mM potassium phosphate, pH 7.0, unless
mentioned otherwise. Spectra were corrected for volume
changes, and the background with buffer or liposome
suspension without peptide was subtracted. In the case of
tryptophan quenching by KI, additional controls were
performed with KCl instead of KI. All experiments were
repeated in three to five independent experiments. Data are
presented either by a typical experiment or as the means with
standard deviation.
RESULTS
Membrane Interaction. The interaction of Ac-MB21-NH2
and dermaseptin S3(1-16)-NH2 with the phospholipid
surface was followed by exploiting tryptophan fluorescence.
Since Ac-MB21-NH2 lacks an endogenous tryptophan resi-
due, phenylalanine at position 1 was substituted for a
tryptophan, and the resulting peptide, F1W-Ac-MB21-NH2,
was obtained after solid-state synthesis. (F1W-Ac-MB21-
NH2 was equipotent to Ac-MB21-NH2 in dissipating the ¢ª
in target cells; data not shown).
The interaction of F1W-Ac-MB21-NH2 with PC liposomes
results in a blue shift of the emission maximum of about 7
nm and an increase in quantum yield (31%) (Figure 1A).
The tryptophan of F1W-Ac-MB21-NH2 inserted more deeply
into PG than into PC liposomes, as the emission blue shift
in the case of PG liposomes was much larger, i.e., 21 nm,
with an almost 2-fold (88%) increase in fluorescence quan-
tum yield (Figure 1C).
Dermaseptin S3(1-16)-NH2 contains a tryptophan residue
at position 3. W3 of dermaseptin shows a negligible blue
shift in its fluorescence maximum (1 nm) and quantum yield
(2%) upon interaction with PC liposomes (Figure 1E). In
contrast, upon interaction with PG liposomes, a very large
blue shift (34 nm) and increase in fluorescence quantum yield
(64%) is observed (Figure 1G), which suggests that the
tryptophan of this peptide selectively inserts into anionic
lipids.
Insertion of the tryptophan of F1W-Ac-MB21-NH2 and
of dermaseptin S3(1-16)-NH2 resulted in the same emission
peak shift within a large range of peptide/phospholipid
ratios: 1/25 to 1/750 (data not shown). This suggests that
the insertion of the tryptophans does not depend on the
peptide/lipid ratio.
FIGURE 1: Liposome interaction of peptides measured by tryptophan fluorescence. Spectra of F1W-Ac-MB21-NH2 (panels A-D) and
dermaseptin S3(1-16)-NH2 (panels E-H) in the presence (+) and absence (-) of liposomes. Panels: A and E, PC liposomes; B and F,
ergosterol/PC liposomes; C and G, PG liposomes; and D and H, ergosterol/PG liposomes. Peptides and phospholipid vesicles were present
at 2 and 50 íM, respectively.
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Fungal membranes contain ergosterol. In the case of yeast
membranes, ergosterol/phospholipid molar ratios can even
be as high as 0.81 (8) or 0.94 (9) but not higher than 1.0
(10). The effect of ergosterol on the interaction of both
amphipatic peptides with the membrane was determined.
Both with F1W-Ac-MB21-NH2 (Figure 1B,D) and with
dermaseptin S3(1-16)-NH2 (Figure 1F,H), the presence of
ergosterol had little effect on the size of the induced peak
blue shift. Therefore, it seems that ergosterol hardly alters
the extent of peptide association and insertion into the
membrane. Ergosterol, however, limited the increase in
fluorescence quantum yield: compare Figure 1B,D,F,H (with
ergosterol) with the corresponding Figure 1A,C,E,G, respec-
tively (without ergosterol).
To determine the orientation of the peptides relative to
the lipid surface, experiments were performed with water-
soluble (acrylamide and potassium iodide) and membrane-
embedded quenchers (5- and 16-doxyl-PC) of tryptophan
fluorescence. The presence of PC liposomes (triangles, Figure
2A,B) slightly reduced the acrylamide quenching (compare
with no liposomes, circles, Figure 2A,B) but had no effect
on the potassium iodide quenching (Figure 2C,D). This
indicates that the tryptophan residues do not insert deeply
into the PC membranes. In contrast, with PG liposomes, the
effectiveness of acrylamide and KI was markedly reduced
(squares, Figure 2A-D). This suggests that the tryptophan
residues of F1W-Ac-MB21-NH2 and dermaseptin S3(1-16)-
NH2 insert into the anionic membranes, thereby becoming
less accessible to the aqueous quenchers. The presence of
ergosterol (open symbols, Figure 2A-D) either in suspension
or incorporated into the liposomes did not affect the
efficiency of quenching (compare with the corresponding
closed symbols).
To assay the depth of penetration, the quenchers 5- and
16-doxyl-PC were used in experiments with F1W-Ac-MB21-
NH2 (Figure 3A,C) and dermaseptin S3(1-16)-NH2 (Figure
3B,D). The quenching groups of these molecules are at
different depths (positions 5 and 16 of the acyl chains), and
they are present in both leaflets of the liposome membrane.
Quenching by the doxyl-PC molecules was much stronger
when the peptides were bound to PG liposomes (Figure
3C,D) as compared to PC liposomes (Figure 3A,B). In all
cases, 5-doxyl-PC was more effective in quenching than 16-
doxyl-PC. The presence of ergosterol in the liposomes (gray
bars) had no major effect on the extent of quenching. Taken
together, these data suggest that the amino termini of Ac-
MB21-NH2 and dermaseptin S3(1-16)-NH2 penetrate into
the acyl chain region of anionic phospholipid membranes.
Lipid-Induced Secondary Structure. Circular dichroism
was used to analyze the effect of the liposomes on the
secondary structure of the peptides. In aqueous solution, Ac-
MB21-NH2 (Figure 4A) and dermaseptin S3(1-16)-NH2
(Figure 4B) are present in random coil structure (Figure 4,
curves a). Some secondary structure was elicited in Ac-
MB21-NH2 (possibly â-sheet or a mixture of â-sheet and
R-helix) by liposomes composed of PC (Figure 4A, curve
c) or PC/ergosterol (Figure 4A, curve b). On the other hand,
neither PC liposomes nor PC/ergosterol liposomes had an
effect on the structure of dermaseptin S3(1-16)-NH2 (Figure
4B, curves c and b, respectively). By contrast, PG (Figure
4A,B, curve e) and PG/ergosterol (Figure 4A,B, curve d)
liposomes clearly induce negative ellipticity at 208 and 222
nm with both peptides, which is characteristic for R-helix
formation.
Ac-MB21-NH2 and Dermaseptin S3(1-16) Dissipate ¢ª
in Liposomes. Membrane permeabilization by Ac-MB21-
FIGURE 2: Stern-Volmer plots of quenching of tryptophan
fluorescence: A and C, F1W-Ac-MB21-NH2; B and D, dermaseptin
S3(1-16)-NH2. Quenching was done with acrylamide and potas-
sium iodide without lipids (b) and in the presence of 40 íM
ergosterol suspension (O), PC liposomes (1), ergosterol/PC lipo-
somes (3), PG liposomes (9), or ergosterol/PG liposomes (0).
Peptides and phospholipid vesicles were present at 2 and 50 íM,
respectively.
FIGURE 3: Quenching of tryptophan fluorescence by doxyl-PC: A
and C, F1W-Ac-MB21-NH2; B and D, dermaseptin S3(1-16)-NH2.
PC liposomes (A and B; 50 íM phopholipid) and PG liposomes
(C and D; 50 íM phospholipid) with or without 10% of 5- or 16-
doxyl-PC were added to a solution containing 2 íM F1W-Ac-
MB21-NH2 or dermaseptin S3(1-16)-NH2. The tryptophan fluo-
rescence spectra were recorded before and after addition. Bars:
solid, liposomes without ergosterol; open, liposomes of ergosterol/
phospholipid.
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NH2, F1W-Ac-MB21-NH2, and dermaseptin S3(1-16)-NH2
was followed by measuring their ability to dissipate a
valinomycin-induced ¢ª in liposomes (Figure 5). In the case
of PC liposomes, Ac-MB21-NH2 (Figure 5A) and F1W-Ac-
MB21-NH2 (Figure 5B) showed a low ¢ª dissipating
activity. In contrast, dermaseptin S3(1-16)-NH2 (Figure 5C)
was completely ineffective. All three peptides more ef-
ficiently dissipated the ¢ª in anionic PG liposomes. Ac-
MB21-NH2 and F1W-Ac-MB21-NH2 had identical activity,
while dermaseptin S3(1-16)-NH2 appeared less effective.
The presence of ergosterol had little effect on the effective-
ness of these peptides.
The capacity of Ac-MB21-NH2 (Figure 6A) and der-
maseptin S3(1-16)-NH2 (Figure 6B) to dissipate the ¢ª in
liposomes of varying composition was further investigated.
Since dermaseptin S3(1-16)-NH2 was less effective than Ac-
MB21-NH2, a nearly 6-fold higher concentration of der-
maseptin S3(1-16)-NH2 was used. The rate of ¢ª dissipa-
tion was affected by the lipid composition as follows: the
presence of 50% (w/w) of a conic, zwitterionic (PE) or 10%
of a conic, neutral [dioleoylglycerol (DOG)] lipid reduced
the rate of ¢ª dissipation, while a cylindric, anionic lipid
(PG) enhances this rate. The presence of 50% (w/w) of the
anionic PS enhanced the dissipation rate only slightly
compared to pure PC liposomes. When its charge is
neutralized, PS behaves like a conic lipid. For Ac-MB21-
NH2 (Figure 6A) PS reduced the dissipation rate compared
to pure PG, but for dermaseptin S3(1-16)-NH2 (Figure 6B)
no significant effect was observed. The inhibitory effect of
(potentially) conic lipids (PS, PE, DOG) is stronger in the
case of Ac-MB21-NH2 than in the case of dermaseptin S3-
(1-16)-NH2. CD measurements with each peptide showed
identical peaks at 222 nm when PG, PG/PE, and PG/PC
liposomes were compared (data not shown). This suggests
that the percentage of R-helix of each peptide is the same in
these cases. Therefore, it is unlikely that the lower ¢ª
dissipating activity of Ac-MB21-NH2 in PG/PE liposomes
compared to PG liposomes would be a consequence of the
peptide structure.
DISCUSSION
Herein we report on the liposome interactions of the
designed Ac-MB21-NH2 peptide and dermaseptin S3(1-16)-
NH2. The aim of this study is to understand the broad target
specificity of these peptides in terms of the phospholipid
selectivity.
We show for Ac-MB21-NH2 and dermaseptin S3(1-16)-
NH2 that the ability to dissipate the ¢ª correlates with the
capacity to insert into a membrane and the formation of an
R-helical structure. Previously, an R-helical structure forma-
tion has also been observed for the related dermaseptin S1-
(1-18)-NH2 (11).
The presence of anionic phospholipids seems to enhance
lipid interaction in our experiments, suggesting that a strong
electrostatic interaction of these cationic peptides with the
negatively charged lipid surface is a requirement for activity.
These lipids are abundantly present in the outer leaflet of
the cytoplasmic membrane of bacteria, explaining the high
FIGURE 4: Lipid-induced secondary structure: A, Ac-MB21-NH2
(98 íM), and B, dermaseptin S3(1-16)-NH2 (95 íM). Circular
dichroism spectra without liposomes (a) and in the presence of
ergosterol/PC liposomes (b), PC liposomes (c), ergosterol/PG
liposomes (d), or PG liposomes (e) are shown. The phospholipid
concentration of the liposome suspensions was 2 mM.
FIGURE 5: Dissipation of a valinomycin-induced ¢ª in lipo-
somes: A, Ac-MB21-NH2; B, F1W-Ac-MB21-NH2; C, dermaseptin
S3(1-16)-NH2. Liposomes (74 íM phospholipid concentration after
dilution) prepared with 50 mM potassium phosphate, pH 7.0, were
diluted 72-fold into 50 mM sodium phosphate, pH 7.0. After
addition of valinomycin (250 nM) the development of a ¢ª was
monitored by the decrease in DiSC(3)5 fluorescence. Next, peptide
was added, and the time needed to depolarize the ¢ª for 50% was
determined for PG liposomes (9), ergosterol/PG liposomes (0),
PC liposomes (1), and ergosterol/PC liposomes (3).
11910 Biochemistry, Vol. 39, No. 39, 2000 Moll et al.
activity against these organisms. In yeast plasma membranes,
about 25-30% of the anionic lipids are present in the outer
leaflet (12). Mammalian cells generally do not expose anionic
lipids in the outer leaflet of their plasma membrane and are
not or hardly susceptible to cationic peptides. As a conse-
quence Ac-MB21-NH2 and dermaseptin S3(1-16)-NH2 are
not hemolytic (2, 13).
Ergosterol that is present at high concentration in fungal
and yeast plasma membranes hardly influenced the interac-
tion of Ac-MB21-NH2 and dermaseptin S3(1-6)-NH2 with
the liposomes. Ergosterol, however, further reduced the poor
ability of these peptides to dissipate the ¢ª in liposomes
composed of PC, but not of PG. Sterols have been suggested
to protect membranes to some extent against membrane
active peptides (14, 15).
In contrast to anionic liposomes, zwitterionic PC liposomes
induce no significant structure in dermaseptin, but with Ac-
MB21-NH2, â-sheet or a mixture of â-sheet and R-helix is
formed. Strikingly, Ac-MB21-NH2 seems to interact and
penetrate PC liposomes, whereas this interaction is not
apparent with dermaseptin.
Our quenching studies of inserted Trp residues indicate a
surface interaction without deep penetration. In the case of
R-helical dermaseptin S3(1-16)-NH2, the large tryptophan-3
blue shift results possibly partly from the neighboring
hydrophobic isoleucine (Figure 7). Some data are available
on the self-association of the dermaseptins S1, S3, S4, b,
and B, the precursor of b (4, 16, 17). Our data indicate that
the association of Ac-MB21-NH2 and dermaseptin S3(1-
16)-NH2 with anionic lipids correlates with activity, but it
is not clear if the molecules are present in an aggregated
state.
Little is known about how these peptides permeabilize
membranes. Mor and Nicolas (11) suggested a barrel stave-
like pore model for demaseptin S1. Ac-MB21-NH2 and
dermaseptin S3(1-16)-NH2 might be too short to form
membrane-spanning barrel stave pores. Shai and co-workers,
however, have proposed a carpet-like mechanism for these
peptides (18, 19). This model suggests that the membrane
is disrupted when a threshold concentration of in-plane bound
peptide is reached (20). Such a mechanism seems possible
for dermaseptin because of the relatively high dermaseptin/
liposome ratio. In our experiments, the effective peptide/
PG ratio ranged from about 0.002 to 0.04 for Ac-MB21-
NH2 and from 0.01 to 0.14 for dermaseptin S3(1-16)-NH2.
At a surface area of 0.716 nm2/PG molecule (21) and an
average vesicle diameter of 50 nm, these ratios would
correspond to about 25-422 molecules of Ac-MB21-NH2/
vesicle and 127-1566 molecules of dermaseptin S3(1-16)-
NH2/vesicle.
Three different models share local fusion of the membrane
leaflets: the wedge-like model (22, 23), the toroidal model
(24, 25), and the in-plane diffusion model (26). Another
alternative model implies that wedge- or inverted wedge-
shaped peptides insert in-plane into the outer leaflet, causing
a disturbed lipid organization of the outer leaflet (27). The
effects of insertion of “inverted conic peptides” (27, 28)
might be identical to the effects of insertion of peptides with
a small angle …, the angle subtended by the charged residues
FIGURE 6: ¢ª dissipating activity of peptides: A, Ac-MB21-NH2,
and B, dermaseptin S3(1-16)-NH2. Liposomes (74 íM phospho-
lipid concentration after dilution) prepared with 50 mM potassium
phosphate, pH 7.0, were diluted 72-fold into 50 mM sodium
phosphate, pH 7.0. After addition of valinomycin (250 nM) the
development of a ¢ª was monitored by the decrease in DiSC(3)5
fluorescence. Next, Ac-MB21-NH2 (1.5 íM) or dermaseptin S3-
(1-16)-NH2 (8.8 íM) was added, and the time needed to depolarize
the ¢ª for 50% was determined. Liposomes were composed of
the following: PC; PC/PS, 1/1 w/w; PC/PE, 1/1 w/w; PG; PG/PC,
1/1 w/w; PG/PS, 1/1 w/w; PG/PE, 1/1 w/w; PG/DOG, 9/1 w/w.
FIGURE 7: R-Helical wheel presentation of Ac-MB21-NH2 and
dermaseptin S3(1-16)-NH2. Vectors represent the hydrophobic
moments: 0.54 for Ac-MB21-NH2 (A) and 0.51 for dermaseptin
S3(1-16)-NH2 (B) Symbols: closed, hydrophobic residues; open,
hydrophilic residues. … is the angle subtended by the positive
residues that border the hydrophobic part of the helix. Amino acid
hydrophobicity values were from Eisenberg (31).
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(Figure 7). With a decrease in the angle …, the higher the
activity would be (29). Strikingly, … of the more active
(Figure 5) Ac-MB21-NH2 is 60°, which is two times smaller
than … of dermaseptin S3(1-16)-NH2 (Figure 7). Figure 6
shows that conic-shaped lipids are more strongly inhibiting
Ac-MB21-NH2, which has a smaller … than dermaseptin S3-
(1-16)-NH2. For both peptides PS is less stimulatory than
PG. This was also observed in the case of magainin (30)
and might relate to the conic shape that PS may adopt when
interacting with a cationic peptide.
Taken together, the present data on Ac-MB21-NH2 and
dermaseptin S3(1-16)-NH2 suggest that the R-helicity of
the peptides, the angle …, subtended by the charged residues
in R-helical peptides, and the shape and charge of the
phospholipids in the target membrane are important factors
in determining the capacity of the peptides to permeabilize
the membrane. The small angle … in R-helical Ac-MB21-
NH2, as compared to … in dermaseptin S3(1-16)-NH2, might
be responsible for its higher capacity to disturb the lipid
bilayer organization. Conic lipids strongly counteract the
strongly membrane disturbing Ac-MB21-NH2 but counteract
to a lesser extent dermaseptin S3(1-16)-NH2.
ACKNOWLEDGMENT
Shanti Dielbandhousing is gratefully acknowledged for
assistance and Marcel L. de Vocht for help with circular
dichroism measurements. Herman Berendsen, Allen Mark,
and Peter Tieleman are acknowledged for stimulating dis-
cussions.
REFERENCES
1. Mor, A., Amiche, M., and Nicolas, P. (1994) Biochemistry
33, 6642-6650.
2. Mor, A., Hani, K., and Nicolas, P. (1994) J. Biol. Chem. 269,
31635-31641.
3. Nicolas, P., and Mor, A. (1995) Annu. ReV. Microbiol. 49,
277-304.
4. Ghosh, J. K., Shaool, D., Guillaud, P., Cice´ron, L., Mazier,
D., Kustanovich, I., Shai, Y., and Mor, A. (1997) J. Biol.
Chem. 272, 31609-31616.
5. Charpentier, S., Amiche, M., Mester, J., Vouille, V., Le Caer,
J.-P., Nicolas, P., and Delfour, A. (1998) J. Biol. Chem. 273,
14690-14697.
6. Coote, P. J., Holyoak, C. D., Bracy, D., Ferdinando, D. P.,
and Pearce, J. A. (1998) Antimicrob. Agents Chemother. 42,
2160-2170.
7. Sims, P. J., Waggoner, A. S., Wang, C.-H., and Hoffman, J.
F. (1974) Biochemistry 13, 3315-3330.
8. Rodriguez, R. J., Low, C., Bottema, C. D. K., and Parks, L.
W. (1985) Biochim. Biophys. Acta 837, 336-343.
9. Patton, J. L., and Lester, R. L. (1991) J. Bacteriol. 173, 3101-
3108.
10. van der Rest, M. E., Kamminga, A. H., Nakano, A., Anraku,
Y., Poolman, B., and Konings, W. N. (1995) Microbiol. ReV.
59, 304-322.
11. Mor, A., and Nicolas, P. (1994c) J. Biol. Chem. 269, 1934-
1939.
12. Cerbo´n, J., and Caldero´n, V. (1994) Eur. J. Biochem. 219,
195-200.
13. Bhakoo, M. (1996) International Patent WO 96/28468.
14. Matsuzaki, K., Sugishita, K., Fujii, N., and Miyajima, M.
(1995) Biochemistry 34, 3423-3429.
15. Schagina, L. V., Korchev, Y. E., Grinfeld, A. E., Lev, A. A.,
and Blasko, K. (1992) Biochim. Biophys. Acta 1109, 91-96.
16. Pouny, Y., Rapoport, D., Mor, A., Nicolas, P., and Shai, Y.
(1992) Biochemistry 31, 12416-12423.
17. Strahilevitz, J., Mor, A., Nicolas, P., and Shai, Y. (1994)
Biochemistry 33, 10951-10960.
18. Gazit, E., Boman, A., Boman, H. G., and Shai, Y. (1995)
Biochemistry 34, 11479-11488.
19. Shai, Y. (1995) Trends Biol. Sci. 20, 460-465.
20. Shai, Y. (1999) Biochim. Biophys. Acta 1462, 55-70.
21. Smaal, E., Mandersloot, J., Demel, R. A., de Kruijff, B., and
de Gier, J. (1987) Biochim. Biophys. Acta 897, 180-190.
22. Driessen, A. J. M., van den Hooven, H. W., Kuiper, W., van
de Kamp, M., Sahl, H.-G., Konings, R. N. H., and Konings,
W. N. (1995) Biochemistry 34, 1606-1614.
23. Moll, G. N., Konings, W. N., and Driessen, A. J. M. (1998)
J. Bacteriol. 180, 6565-6570.
24. Matsuzaki, K., Murase, O., Fuji, N., and Miyajima, K. (1996)
Biochemistry 35, 11361-11368.
25. Ludtke, S. J., He, K., Heller, W. T., Harroun, T. A., Yang, L.,
and Huang, H. W. (1996) Biochemistry 35, 13723-13728.
26. Bechinger, B. (1999) Biochim. Biophys. Acta 1462, 157-183.
27. Tytler, E. M., Segrest, J. P., Epand, R. M., Nie, S.-Q., Epand,
R. F., Mishra, V. K., Venkatachalapathi, Y. V., and Ananthar-
amaiah, G. M. (1993) J. Biol. Chem. 268, 22112-22118.
28. Epand, R. M. (1998) Biochim. Biophys. Acta 1376, 353-368.
29. Dathe, M., and Wieprecht, T. (1999) Biochim. Biophys. Acta
1462, 71-87.
30. Matsuzaki, K., Sugishita, K.-I., Ishibe, N., Ueha, M., Nakata,
S., Miyajima, K., and Epand, R. M. (1998) Biochemistry 37,
11856-11863.
31. Eisenberg, D. (1984) Annu. ReV. Biochem. 53, 595-623.
BI000917A
11912 Biochemistry, Vol. 39, No. 39, 2000 Moll et al.
